[P53 genes and malignant hematologic diseases].
Mutations of the P53 tumor suppressor gene represent the most common genetic lesion in human solid tumors. In hematological malignancies, P53 alterations are detected in the evolution of the chronic myelogenous leukemia to myeloid blast crisis. P53 mutations were also found to be associated with Burkitt's lymphoma and HTLV-1 related adult T-cell leukemia. These results support the notion that alterations of the P53 gene may be involved in the progression of these hematological diseases.
Jonveaux
P
P
INSERM U 301, Institut de génétique moléculaire, Paris, France.
D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000235:genetics*; D009154:Mutation
Gène P53 et hémopathies malignes.